SCNX
Scienture Holdings, Inc.Company Information
- Company Name
- Scienture Holdings, Inc.
- CIK
- CIK0001382574
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- SCNX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- SCNX
SEC filing data through
Insider Sentiment
- Last purchase
- 2022-08-25
- Last sale
- 2021-06-21
- Shares purchased (TTM)
- 13,500
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1,846,097
- Shares outstanding
- 39,615,815
- Ownership
- 4.66%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -19.78%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | - | - | - | - | - | - | - | - | - | 3 | 0 | 0 | ||||||
| Cash Equivalents At Carrying Value | 8 | 4 | 7 | - | - | - | 0 | - | - | - | - | - | ||||||
| Cash | - | 4 | 7 | 0 | 0 | 2 | 0 | 1 | 8 | - | 0 | - | ||||||
| Accounts Receivable Net Current | 0 | 1 | 1 | 1 | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 3 | ||||||
| Prepaid Expense And Other Assets Current | - | - | - | - | - | - | - | 1 | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 1 | 0 | 0 | 0 | ||||||
| Notes And Loans Receivable Net Current | - | - | - | - | - | - | 1 | - | - | 1 | 1 | 1 | ||||||
| Accounts And Other Receivables Net Current | - | - | - | - | - | - | - | - | - | 9 | 0 | 0 | ||||||
| Other Receivables Net Current | - | - | - | - | - | 4 | 4 | 5 | 2 | - | 1 | - | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Deferred Offering Costs | - | 0 | 0 | - | 1 | - | 1 | 0 | 0 | - | - | - | ||||||
| Assets Current | 9 | 5 | 8 | 1 | 1 | 8 | 6 | 7 | 12 | 14 | 3 | 6 | ||||||
| Restricted Cash Noncurrent | 3 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deposits Assets Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes And Loans Receivable Net Noncurrent | 5 | 5 | 5 | 5 | - | - | - | - | - | - | - | - | ||||||
| Interest Receivable Noncurrent | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 70 | 71 | 71 | 76 | 76 | 76 | 76 | 76 | - | - | 9 | 9 | ||||||
| Goodwill | - | - | - | 21 | 21 | 21 | 21 | 8 | - | - | - | 5 | ||||||
| Long Term Investments | - | - | - | - | - | - | - | 3 | 3 | 3 | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | 10 | - | ||||||
| Deferred Income Tax Assets Net | - | - | - | 1 | 1 | 1 | 1 | - | - | - | - | - | ||||||
| Assets | 88 | 81 | 84 | 105 | 84 | 84 | 105 | 94 | 15 | 105 | 13 | 22 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 4 | 3 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | - | - | - | 7 | 5 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Other Liabilities Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Loans Payable Current | - | - | - | 1 | 1 | 1 | 0 | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | - | - | - | 2 | 2 | 2 | 2 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | 8 | - | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Notes Payable Current | 1 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 3 | 3 | 3 | 7 | 8 | 7 | 8 | 5 | 3 | 3 | 12 | 9 | ||||||
| Convertible Long Term Notes Payable | - | - | - | - | 2 | 1 | 1 | 2 | - | - | - | - | ||||||
| Derivative Liabilities Noncurrent | - | - | - | - | - | - | 2 | - | - | - | - | - | ||||||
| Derivative Liabilities | - | - | - | - | 2 | 2 | 2 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Other Long Term Notes Payable | 10 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 11 | 11 | 11 | 14 | 14 | 14 | 14 | - | - | - | - | - | ||||||
| Liabilities | 24 | 14 | 14 | 22 | 26 | 25 | 26 | 9 | 3 | 3 | 12 | 10 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 151 | 151 | 151 | 135 | 127 | 123 | 118 | 117 | 38 | 38 | 34 | 33 | ||||||
| Retained Earnings Accumulated Deficit | -87 | -84 | -81 | -52 | -49 | -42 | -39 | -32 | -27 | -25 | -33 | -22 | ||||||
| Stockholders Equity | 64 | 67 | 70 | 83 | 78 | 81 | 79 | 85 | 12 | 14 | 1 | 12 | ||||||
| Liabilities And Stockholders Equity | 88 | 81 | 84 | 105 | 104 | 106 | 105 | 94 | 15 | 17 | 13 | 22 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 7 | ||||||
| Common Stock Shares Issued | 41 | 41 | 41 | 23 | 16 | 13 | 9 | 9 | 1 | 1 | 1 | 1 | ||||||
| Shares Outstanding | 41 | 41 | 41 | 23 | 16 | 13 | 9 | 9 | 1 | 1 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialScienture Holdings, Inc. (SCNX) — SEC Financial Statements & Analysis
Scienture Holdings, Inc. (SCNX) is a pharmaceutical preparations company, incorporated in DE. Scienture Holdings, Inc. trades on Nasdaq as: SCNX. Scienture Holdings, Inc. (SCNX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Scienture Holdings, Inc. carries a market cap of $13.87M, a P/E ratio of -0.37x, a P/B ratio of 0.22x, a P/S ratio of 18.13x, an enterprise value of $5.68M, and an EV/EBITDA multiple of -0.14x. On profitability, it posts a gross margin of 87.14%, an operating margin of -5238.09%, a net margin of -4961.15%, a Return on Equity (ROE) of -53.47%, a Return on Assets (ROA) of -44.15%, and a Return on Invested Capital (ROIC) of -58.13%. Per share, it reports EPS of $-0.96, diluted EPS of $-0.96, free cash flow per share of $-0.36, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 296.24% year-over-year, net income growth of 88.53% year-over-year, and EPS growth of -32.70% year-over-year. On the balance sheet, it maintains a current ratio of 3.04x, a quick ratio of 2.83x, working capital of $6.18M, a debt-to-equity ratio of 0.37x, a debt ratio of 0.27, an interest coverage ratio of -13.07x, free cash flow of $-14.44M (TTM), and net debt of $-8.19M. Figures sourced from SEC EDGAR.
- Market Cap
- $13.87M
- P/E TTM
- -0.37x
- EPS TTM
- $-0.96
- P/B TTM
- 0.22x
- ROE TTM
- -53.47%
- ROA TTM
- -44.15%
- Debt To Equity
- 0.37x
- Free Cash Flow TTM
- $-14.44M
- Net Revenue TTM Growth 1Y
- 296.24%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Scienture Holdings, Inc. in?
Scienture Holdings, Inc. (SCNX) operates in the Pharmaceutical Preparations industry.
What exchange does SCNX trade on?
Scienture Holdings, Inc. (SCNX) trades on the Nasdaq.
Where is Scienture Holdings, Inc. incorporated?
Scienture Holdings, Inc. is incorporated in DE.
When was Scienture Holdings, Inc. (SCNX)'s most recent SEC filing?
Scienture Holdings, Inc. (SCNX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is SCNX's market cap?
Scienture Holdings, Inc. (SCNX) has a market capitalization of $13.87M as of 2026-06-30.
What is SCNX's EPS (earnings per share)?
Scienture Holdings, Inc. (SCNX)'s trailing twelve month EPS is $-0.96 as of 2026-06-30.
What is SCNX's ROE (return on equity)?
Scienture Holdings, Inc. (SCNX)'s trailing twelve month Return on Equity (ROE) is -53.47% as of 2026-06-30.
What is SCNX's ROA (return on assets)?
Scienture Holdings, Inc. (SCNX)'s trailing twelve month Return on Assets (ROA) is -44.15% as of 2026-06-30.
What is SCNX's ROIC (return on invested capital)?
Scienture Holdings, Inc. (SCNX)'s trailing twelve month Return on Invested Capital (ROIC) is -58.13% as of 2026-06-30.
What is SCNX's EV/EBITDA?
Scienture Holdings, Inc. (SCNX)'s trailing twelve month EV/EBITDA is -0.14x as of 2026-06-30.